- Report
- July 2019
- 120 Pages
United States
From €1439EUR$1,500USD£1,240GBP
- Report
- October 2018
- 155 Pages
Europe
From €1238EUR$1,290USD£1,066GBP
- Report
- June 2018
- 245 Pages
Global
From €1679EUR$1,750USD£1,446GBP
- Report
- March 2023
- 235 Pages
Global
From €5277EUR$5,500USD£4,545GBP
- Report
- March 2021
- 345 Pages
Global
From €1319EUR$1,375USD£1,136GBP
€2639EUR$2,750USD£2,273GBP
- Report
- April 2024
- 134 Pages
From €5277EUR$5,500USD£4,545GBP
- Report
- August 2018
- 189 Pages
Global
From €1319EUR$1,375USD£1,136GBP
€2639EUR$2,750USD£2,273GBP
- Report
- April 2018
- 100 Pages
India
From €1727EUR$1,800USD£1,488GBP
- Report
- October 2019
- 71 Pages
United States
From €2159EUR$2,250USD£1,859GBP
- Report
- October 2019
- 117 Pages
Global
From €3982EUR$4,150USD£3,430GBP
- Report
- August 2023
- 73 Pages
Egypt
From €3358EUR$3,500USD£2,892GBP
- Report
- October 2022
- 70 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- March 2023
- 100 Pages
Global
From €2639EUR$2,750USD£2,273GBP
- Report
- April 2023
- 57 Pages
Asia Pacific
From €4749EUR$4,950USD£4,091GBP
- Report
- April 2023
- 120 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- September 2022
- 150 Pages
Middle East, Africa
From €2015EUR$2,100USD£1,735GBP
€2878EUR$3,000USD£2,479GBP
- Report
- September 2022
- 142 Pages
From €2015EUR$2,100USD£1,735GBP
€2878EUR$3,000USD£2,479GBP
- Report
- September 2022
- 152 Pages
North America
From €2015EUR$2,100USD£1,735GBP
€2878EUR$3,000USD£2,479GBP
- Report
- September 2022
- 171 Pages
Europe
From €2015EUR$2,100USD£1,735GBP
€2878EUR$3,000USD£2,479GBP
- Report
- September 2022
- 171 Pages
Asia Pacific
From €2015EUR$2,100USD£1,735GBP
€2878EUR$3,000USD£2,479GBP
Non-invasive prenatal testing (NIPT) is a type of prenatal screening used to detect chromosomal abnormalities in a fetus. It is a safe and accurate method of testing that does not involve any risk to the mother or fetus. NIPT is typically used to detect Down syndrome, trisomy 18, and trisomy 13, as well as other chromosomal abnormalities. It is also used to determine the sex of the fetus. NIPT is becoming increasingly popular as an alternative to traditional invasive prenatal testing, such as amniocentesis and chorionic villus sampling.
NIPT is offered by a variety of diagnostic companies, including Illumina, Natera, Ariosa Diagnostics, and Sequenom. These companies provide a range of services, from laboratory testing to genetic counseling. They also offer a variety of testing options, such as single-gene tests, whole-genome sequencing, and targeted sequencing. Show Less Read more